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Microglial activation has been considered as a crucial process in the pathogenesis of 
neuroinflammation and psychiatric disorders. Several antipsychotic drugs (APDs) have 
been shown to display inhibitory effects on microglial activation in vitro, possibly through 
the suppression of elevated intracellular calcium (Ca2+) concentration. However, the 
exact underlying mechanisms still remain elusive. In this study, we aimed to investigate 
the inhibitory effects of quetiapine (Que), an atypical APD, on microglial activation. We 
utilized a chronic cuprizone (CPZ)-induced demyelination mouse model to determine the 
direct effect of Que on microglial activation. Our results showed that treatment with Que 
significantly reduced recruitment and activation of microglia/macrophage in the lesion of 
corpus callosum and promoted remyelination after CPZ withdrawal. Our in vitro studies 
also confirmed the direct effect of Que on lipopolysaccharide (LPS)-induced activation 
of microglial N9 cells, whereby Que significantly inhibited the release of nitric oxide (NO) 
and tumor necrosis factor α (TNF-α). Moreover, we demonstrated that pretreatment with 
Que, neutralized the up-regulation of STIM1 induced by LPS and declined both LPS 
and thapsigargin (Tg)-induced store-operated Ca2+ entry (SOCE). Finally, we found that 
pretreatment with Que significantly reduced the translocation of nuclear factor kappa B 
(NF-κB) p65 subunit from cytoplasm to nuclei in LPS-activated primary microglial cells. 
Overall, our data suggested that Que may inhibit microglial activation by neutralization of 
the LPS-induced abnormal STIM1-mediated intercellular calcium homeostasis.
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inTrODUcTiOn
Microglia represents an abundant portion of cells that comprise 
the central nervous system (CNS). They are exclusively distrib-
uted in brain and spinal cord and represent about 5–20% of the 
total glial cell population (Lawson et al., 1990). CNS microglia 
cells are resident immune cells of the brain that constantly moni-
tor the cerebral microenvironment to resist pathogens and heal 
injuries (Perry et  al., 1993). Recent research demonstrates that 
microglial activation has a critical role in pathogenesis of neuro-
inflammatory diseases such as multiple sclerosis (MS) (Jack et al., 
2005),  neurodegenerative diseases, such as Alzheimer’s disease 
(AD) (Wang et al., 2015) or Parkinson’s disease (PD) (Qian et al., 
2010), by producing various proinflammatory cytokines and 
free radicals (Kettenmann et  al., 2011; Smith and Dragunow, 
2014; Streit et al., 2014; Probert, 2015). In addition, other studies 
have also linked the importance of microglial activation to the 
pathogenesis associated with schizophrenia (SZ) (Monji et  al., 
2009; Busse et al., 2012; Monji et al., 2013; Al-Hakeim et al., 2015; 
An et al., 2015). Specifically, it has been shown that an elevated 
microglial density or microglial activation has been observed in 
the brains of patients with SZ (Steiner et al., 2008; Doorduin et al., 
2009; Kato et  al., 2013; Watkins and Andrews, 2015). Atypical 
antipsychotic drugs (APDs), such as risperidone, olanzapine, and 
aripiprazole have been reported to reduce the secretion of TNF-α 
and nitric oxide (NO) from activated microglia (Hou et al., 2006; 
Bian et al., 2008; Kato et al., 2008). These studies suggested that 
the pharmacological action of the antipsychotics on microglia 
may underlie the reported benefits associated with the use of 
these agents in patients with SZ (Kato et al., 2011).
Recently, accumulating evidence points to oligodendroglia 
dysfunction in regard to the demyelination known to be involved 
in the pathogenesis of SZ. As such, drugs that target oligoden-
droglia function are being investigated for their potential benefit 
in SZ (Ren et  al., 2013; Roussos and Haroutunian, 2014). Que 
is an atypical APD that has been demonstrated to have superior 
therapeutic effects on cognitive symptoms displayed by patients 
with SZ as well as other neurological disorders (Kasper and 
Muller-Spahn, 2000; Riedel et al., 2007). It has been found that 
Que can protect mice from CPZ-induced microglial activation 
and myelin breakdown (Zhang et  al., 2008; Shao et  al., 2015). 
Que has also been shown to modulate immune responses in an 
experimental autoimmune encephalomyelitis (EAE) model of 
MS (Mei et al., 2012). It has also been shown to inhibit release 
of proinflammatory factors from activated microglia in culture 
(Bian et al., 2008). However, the underlying mechanism by which 
Que regulates microglial activation remains elusive. Meanwhile, 
it is also unclear as to the specific actions of Que on microglial 
activation during remyelination.
Interestingly, research has suggested that the elevation of 
intracellular calcium (Ca2+) is critical in cell proliferation, 
migration, or ramification (Mizoguchi et  al., 2014). Previous 
studies reported that pretreatment with APDs (Kato et al., 2008; 
Mizoguchi et  al., 2014) significantly inhibited the release of 
proinflammatory cytokines and/or NO from activated microglia 
by suppression of elevation of intracellular calcium concentra-
tion ([Ca2+]i). Henceforth, it is possible that Que may also 
inhibit microglial activation via suppression of [Ca2+]i elevation; 
however, the molecular pathway for this proposed effect is yet 
to be defined. Among Ca2+ regulation in non-excitable cells, the 
main Ca2+ influx mechanism is called store-operated Ca2+ entry 
(SOCE) (Hoffmann et al., 2003; Qian et al., 2010; Kettenmann 
et  al., 2011; Brawek and Garaschuk, 2013; Heo et  al., 2015). 
Studies also reported that Ca2+ release from SOCE stimulates 
an intercellular proinflammatory signal (Ohana et  al., 2009; 
Mizoguchi et  al., 2011), indicating that SOCE may contribute 
to the release of proinflammatory substances during microglial 
activation (Kraft, 2015; Michaelis et  al., 2015; Moccia et  al., 
2015). However, to the best of our knowledge, there is currently 
no study that has addressed this issue.
In the present study, using a CPZ-induced chronic demyelina-
tion mouse model, as well an in vitro systems using lipopolysac-
charide (LPS)-induced activated microglial, we demonstrated 
that Que dramatically attenuated microglial activation and pro-
moted myelin repair. We also found that Que can neutralize the 
STIM1-mediated elevation of Ca2+ entry (SOCE) and subsequent 
NFκB activation in LPS-induced activated microglia.
MaTerials anD MeThODs
animals and experimental Manipulations
C57BL/6 mice (male, 6  weeks old, 22–25  g) were obtained 
from the Animal Facility Centre of the Third Military Medical 
University, PR China. The animals were housed at this facility 
with a 12-h dark/12-h light cycle, at a constant temperature of 
22 ±  1°C and a relative humidity of 60%. All procedures were 
performed in accordance with the guidelines set and approved 
by the Laboratory Animal Welfare and Ethics Committee of the 
Third Military Medical University.
C57BL/6 mice were randomly assigned to one of the following 
four groups: control (CTL), in which mice fed regular chow and 
drank distilled water for 12 weeks; CPZ, in which mice fed 0.2% 
CPZ for 12 weeks to induce a chronic demyelination (Matsushima 
and Morell, 2001); Veh, in which mice fed 0.2% CPZ for 12 weeks, 
then fed regular chow, and drank vehicle water for 2 weeks; Que, 
in which mice fed 0.2% CPZ for 12 weeks, and then fed regular 
chow, and drank Que-containing water for 2 weeks.
Drug Treatments
Cuprizone (bis-cyclohexanone oxaldihydrazone) was purchased 
from Sigma-Aldrich (St. Louis, MO, USA). As previously 
described in other studies, 0.2% CPZ was mixed into the ground 
standard rodent chow. Que was provided by Astra Zeneca 
(Wilmington, DE, USA) and dissolved in distilled water. The 
mice ingested 10 mg/kg/day of Que according to our previously 
established in house methods with this model (Xiao et al., 2008; 
Zhang et al., 2008).
Lipopolysaccharide (Escherichia coli, E5:055) was purchased 
from Sigma (St. Louis, MO, USA). Fetal bovine serum (FBS) 
was purchased from Hyclone (Logan, UT, USA). Thiazolylblue 
(MTT) was from Beyotime Institute of Biotechnology, China 
(Shanghai, China). Iscove’s Modified Dulbecco’s medium 
(IMDM) was from Hyclone (Logan, UT, USA) and Dulbecco’s 
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Modified Eagle Medium (DMEM) was from Gibco (Life 
technologies).
Que was dissolved into 20 mM of dimethyl sulfoxide (DMSO) 
and then diluted into 2 mM of PBS for experiments. The concen-
trations of Que were 0.1, 1, 10, and 50 μM.
histology and immunohistochemistry
Histology and immunohistochemistry were performed as previ-
ously described (Wang et al., 2010). Briefly, 20 μm serial frozen 
sections between bregma −0.94 and bregma −1.8 [according 
to mouse atlas by Paxinos and Franklin (2004)] were analyzed. 
Sections were stained for myelin with Luxol fast blue (LFB)/
periodic acid-Schiff (PAS) base. For immunohistochemistry, 
sections were quenched with H2O2 blocked for 30  min in PBS 
containing 3% bovine serum albumin, 0.1% Triton X-100, and 
then incubated overnight with primary antibody. The primary 
antibody myelin basic protein (MBP) (Goat IgG; Santa Cruz) was 
used as a myelin protein. After washing, sections were further 
incubated with biotinylated secondary antibody (Daco) for 1 h, 
followed by peroxidase-coupled avidin–biotin complex (ABC kit, 
Vector Laboratories).
n9 cell culture
The murine microglial cell line N9 (Provided by Prof. Yun Bai, 
Department of Medical Genetics, TMMU, China) were grown 
in DMEM supplemented with 10% heat-inactivated FBS, 100 U/
ml penicillin, 100  μg/ml streptomycin, and 2  mM glutamine 
in humidified atmosphere of 95% air and 5% CO2 at 37°C. The 
medium was changed every 2 days. Cells were plated at a density 
of 4 × 104 cells/well onto 96-well microtiter plates for MTT and 
nitrite assay. Que with or without LPS (100 ng/ml) was added to 
the culture medium of N9 cells for 24 h.
Primary Microglial cell culture
Primary microglia cultures from C57BL/6 mice, cells were pre-
pared from postnatal days 1–3. The brain tissue was dissociated 
in ice-cold HBSS. After removal of the cerebellum and subcorti-
cal tissue, meninges and blood vessels were dissociated under a 
dissecting microscope. The cortex was placed in an additional 
petri dish with precooled DMEM/F12 medium. The petri dish 
was placed on ice. The cerebral cortex was cut into about 1 mm3 
blocks, digested in 0.125% trypsin at 37°C for 5  min, and agi-
tated into a cell suspension. Cell aggregates were collected by 
centrifugation (1000 ×  g, 5  min), resuspended in DMEM/F12, 
containing 10% FBS and antibiotics (40  U/ml penicillin and 
40 μg/ml streptomycin) and cultured in 95% air and 5% CO2 at 
37°C. Floating microglia were harvested every week (between 2 
and 7 weeks) and reseeded into 75 cm2 culture flask to give pure 
microglia cultures. The medium was replaced once every 3 days.
MTT assay
Cell viability was evaluated by the MTT reduction assay as 
described previously (Niu et  al., 2010). The cells were seeded 
in a 96-well plate for 24  h before being exposed to Que alone 
(10 μm) or Que with LPS (100 ng/ml) for 24 h. MTT solution 
(0.5 mg/ml, Beyotime, Nantong, China) was then added to each 
well and the cells were incubated for 1 h at 37°C and in 5% CO2. 
Subsequently, the supernatant was removed and the formation of 
farmazan was solubilized with DMSO and measured at 540 nm 
with SpectraMax M2e spectrophotometer (Molecular Devices, 
Sunnyvale, CA, USA).
nitrite Production assessment
Accumulation of nitrite (NO2−) in the culture media, an indica-
tor of NO synthase activity, was measured by Griess Reaction. 
Cells at density of 3 ×  104  cells/well were plated onto 96-well 
microtiter plates. Que with or without LPS (100  ng/ml) were 
added to the culture medium of N9 microglial cells for 48  h. 
Fifty microliters of culture supernatants were mixed with 50 μl 
Griess reagents (Part I: 1% sulfanilamide; Part II: 0.1% naphthy-
lethylene diamide dihydrochlride and 2% phosphoric acid) at 
room temperature at 540 nm using the microplate reader. Nitrite 
concentration was calculated with reference to a standard curve 
of sodium nitrite.
immunofluorescent staining
Cells on glass cover slips were fixed with 4% paraformalde-
hyde (PFA), rinsed with 0.01M PBS, incubated with 0.3% 
TritonX-100 for 5 min and blocked in 3% BSA for 60 min. Then 
glass cover slips were incubated in following primary antibodies 
overnight at 4°C: for NFκB p65 (rabbit IgG; Santa Cruz), for 
microglia CD11b (mouse IgG; Chemico), washed with PBS, 
and incubated with fluorescence-conjugated second antibodies 
at 4°C overnight. The method used for brain sections has been 
described previously (Wang et al., 2010). The immunoreactivity 
was determined using a 20× objective lens on a fluorescence 
microscope (Olympus BX-60) and a TCS SP5 confocal laser 
scanning microscope (Leica) with an excitation wavelength 
appropriate for 488 or 528  nm. Cell nuclei were stained with 
DAPI (Sigma, 0.1  μg/ml in PBS) at room temperature for 
15 min. Cell counting was conducted on nine randomly chosen 
fields for each cover slip by using the densitometer Image Pro 
Plus image analysis system. There were two cover slips in each 
group.
intracellular ca2+ imaging
Microglial N9 cells were plated at 1 × 106 cells on poly-d-lysine-
coated, glass-bottomed culture dishes. Cells were incubated in 
medium containing 2 μM Fura-3 for 15  min at 37°C. Before 
Ca2+ measurements were conducted, the culture dishes were 
washed with Ca2+-free standard extracellular solution (SES) 
buffer. Cells were incubated with medium alone and 50  nM 
Que for 20  min before addition of LPS or thapsigargin (Tg). 
Tg is non-competitive inhibitor of the sarco/endoplasmic 
reticulum (ER) Ca2+ ATPase (SERCA). During fluorescent 
measurements, the cells were continually perfused with a 
regular solution (37°C) containing 150 mM NaCl, 5 mM KCl, 
1 mM MaCl2, 10 mM glucose, and 10 mM HEPES at pH 7.4 with 
NaOH and either 1–2 mM CaCl2 or 0.5 mM EGTA (Ca2+-free). 
Fluorescent measurements were performed by imaging the 
Fluo-3 AM-loaded microglia using a laser scanning confocal 
microscope (Olympus IV 1000). Images were acquired using 
an olympus fluoview Ver.2.1c Viewer software. Relative average 
intracellular Ca2+ concentration values were obtained from at 
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least 20–30 microglial cells and the results obtained from at least 
three or four individual experiments.
Quantitative rT-Pcr
RNA was isolated from cultures using TRIzol Reagent 
(Invitrogen) and total RNA (5 mg) was reverse transcribed using 
PrimeScript™ RT-PCR Kit (Takara) according to the manufac-
turer’s instructions. The cDNA was analyzed by real-time PCR 
with the Rotor Gene6000 (Corbertt Research, Australia) accord-
ing to the protocol provided by the manufacturer and 2−ΔΔCt 
method. Briefly, PCRs were performed using SYBR premix Ex 
Taq (Takara) in a final volume of 20 μl. The specific primers of 
target genes were as follows: TNF-α (5′-GACGTGGAACTGG 
CAGAAGAG-3′, 5′-TGCCACAAGCAGGAATGAGA-3′), Stim1 
(5′-TCTFCATGACCTTCAGGAAA-3′, 5′-GGTGGACCTTCTC 
TACTTCCAC-3′), Stim2 (5′-AGTTGCCCTGCTCTGTATCG-3′, 
5′-TGAAGCTGTTGTCTGGCACTT-3′), Orai1 (5′-TACTTAAG 
CCGCGCCAAG-3′, 5′-ACTTCCACCATCGCTACCA-3′), and 
GAPDH (5′-CAGCAAGGACACTGAGCAAGA-3′, 5′-GCCCCT 
CCTGTTATTATGGGG-3′).
statistical analysis
One-way or two-way analysis of variance (ANOVA) was used to 
test statistical significance of three or more experimental groups, 
which was followed by Dunnett’s post  hoc or Tukey’s post  hoc 
test. Comparison between two experimental groups was made 
by the Student’s t-test. A probability of P < 0.05 was considered 
 statistically significant.
resUlTs
Que inhibits the activation of Microglia/
Macrophage in corpus callosum lesions
To investigate the effect of Que on microglial activation involved 
in myelin defects, we used long-term CPZ-treated mice to mimic 
the neuroinflammation and white matter deterioration known to 
occur in the chronic disease phase (Figure 1A). Fast blue-staining 
results showed that almost no myelin fibers could be detected in 
corpus callosum (CC) in CPZ group vs. the control group (CTL) 
(Figure 1B). After CPZ withdrawal, remyelination was observed. 
However, the extent of myelin repair of CC was much higher in 
the Que group compared to that in the Veh group (Figure 1C). 
Similar demyelination and remyelination trends were observed 
in MBP-positive immunostaining (Figures  1B,C). Statistical 
analysis revealed a significant difference between CTL and CPZ 
group in terms of the optical density of MBP immunostaining, 
while Que group significantly increased in optical density of MBP 
staining compared to Veh group (Figure 1D). Interestingly, the 
accumulation of activated microglia/macrophages was observed 
by CD11b staining in the CC of CPZ group while only sporadi-
cally seen in CTL group (Figure 1B). After CPZ withdrawal, the 
density of CD11+ cells (active microglia) decreased slightly but 
still remained at an elevated level that was not seen in the Que 
group (Figures 1C,E). These data suggest that Que can alleviate 
the recruitment and activation of microglia and promote myelin 
repair in CPZ-induced chronic mouse model of demyelination.
Que Decreases the release of nO and 
TnF-α from activated n9 Microglial cells 
induced by lPs
To exclude non-specific effects of Que on microglial cells, MTT 
assay was performed to observe cell viabilities of N9 microglial 
cells treated with or without Que. Results showed that Que had 
no significant effect on cell viabilities at various concentrations 
under 100 μM, in which significant toxicity could be observed 
(Figure 2A). In addition, cell viability of N9 cells were tested after 
exposure to LPS at various concentrations (0, 0.1, 1, 10, 100, and 
1000  ng/ml). The results displayed that LPS had no significant 
effect on cell viabilities (Figure 2B, P > 0.05). However, NO release 
in medium was increased by LPS in concentration-dependent 
manner, which was dramatically inhibited by pretreatment of 
Que (10 μM) (Figure 2C). Similar inhibitory effects of Que on 
TNF-α synthesis were also observed (Figure 2D). As such, our 
results demonstrated that Que did not affect N9 microglia cells 
viability, but decreased the release of NO and TNF-α from N9 
microglial cells induced by LPS.
Que inhibits ca2+ elevation in n9 cells 
induced by lPs and Thapsigargin (Tg)
To determine if Que might affect the Ca2+ signaling pathway, 
which is very important for microglial activation, we utilized Ca2+ 
imaging to measure alterations of [Ca2+]i in N9 cells after stimula-
tion. It was found that LPS induced sustained [Ca2+]i elevation 
due to release of internal ER Ca2+ (left peak, arrow) in Ca2+-free 
imaging buffer. After washing, 2 mM Ca2+ buffer induced [Ca2+]i 
elevation (right peak, arrow) due to Ca2+ influx through the PM, 
namely SOCE (Figure  3A). Pretreatment of Que for 15  min 
showed a significant decrease in the [Ca2+]i level in response to 
LPS stimulation (Figure 3B). These results suggested that Que 
may reduce LPS-stimulated [Ca2+]i by inhibiting activation-
induced Ca2+ channel in PM and Ca2+ influx. In addition, in order 
to verify whether Que affect SOCE in N9 cells, or to examine 
the specificity of Que effects on Ca2+ influx, we investigated the 
effect of Que on TG-induced activation of [Ca2+]i. Stimulation 
of Tg on N9 cells induced both Ca2+ release in ER (left peak in 
Figure  3C) and Ca2+ influx in PM (right peak in Figure  3C); 
pre-treated with Que, however, decreased TG-induced Ca2+ 
turn over (Figures 3C,D). Our results suggest that Que inhibits 
Ca2+ elevation likely by modulation SOCE in N9 microglial cells 
induced by LPS or Tg.
Que inhibits Upregulation of sTiM1 in n9 
cells exposed to lPs
In order to identify the SOCE channels which can be regulated 
by Que treatment in microglial cells, qRT-PCR was performed to 
analyze the mRNA levels for SOCE channel proteins STIM and 
Orai. These SOCE channel proteins were chosen because the inter-
action of STIM on ER and Orai1 on PM was essential for SOCE 
activation (Luik et al., 2006). It was found that LPS-exposed cells 
displayed a significant increase in STIM1 (Figure  4A), STIM2 
(Figure 4C), and Orail (Figure 4B) expression as compared to 
controls (CTLs). Que pretreatment significantly reduced the 
FigUre 1 | effect of Que on microglial activation and remyelination in cPZ-induced chronic demyelinating mouse model. (a) Schematic diagram 
displaying the time course and Que (10 mg/kg/day) treatment on CPZ-induced demyelination and remyelination. C57BL/6 mice were given CPZ for 12 weeks for 
chronic demyelination and start remyelination after CPZ withdrawal. (B) Representative Luxol fast blue staining, MBP and CD11b IF staining for corpus callosum (CC) 
mediolateral area of mice fed with or without CPZ. (c) Representative Luxol fast blue staining, MBP and CD11b IF staining for CC mediolateral areas of mice fed with 
or without Que after CPZ withdraw. (D) Quantification for optical density of MBP expression in CC of indicated groups. (e) Quantification of CD11b+ cells (activated 
microglia) in CC. The scale bars are 200 μm and 20 μm, respectively. Data represent means ± SEM (n = 6 in each group), **p < 0.01 between indicated group.
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upregulation of STIM1 (Figure 4A), but produced no effect on 
Orai1 and/or STIM2 expression (Figures 4B,C).
Que inhibits the Translocation of nF-kB 
p65 in lPs-activated Microglial cells
To further investigate the downstream mechanism of Que inhibi-
tion effect on N9 cell activation, we examined alteration of nuclear 
factor NF-κB activation, which has been implicated in LPS-induced 
microglial activation (Fan et  al., 2015). Immunofluorescence 
staining revealed that the NF-κB p65 subunits were mainly 
expressed in cytoplasm and were barely detectable in the nucleus 
of control (CTL) and Que-treated groups (Que). However, NF-κB 
p65 subunits were intensively expressed in nucleus after LPS 
treatment (Figure 5A). However, Que pretreatment significantly 
reduced the translocation of p65 to nuclei when exposed to LPS 
(Figures 5A,D). Furthermore, we also examined the effect of Que 
FigUre 2 | effect of Que on nO and TnF-α release from n9 cells induced by lPs. (a) MTT assay, cell viability of N9 microglial cells treated with various 
concentrations (0, 0.1, 1, 10, 50, and 100 μM) of Que for 24 h. (B) MTT assay, cell viability of N9 microglial cells treated with various concentrations (0, 0.1, 1, 10, 
100, and 1000 ng/ml) of LPS for 24 h. (c) Griess assay of NO release from N9 cells exposed to various concentrations of LPS for 24 h with or without Que (10 μM) 
pretreatment. (D) qRT-PCR measurement of TNF-α mRNA expression in N9 cells exposed to LPS (100 ng/ml) for 24 h with or without Que (10 μM) pretreatment. 
Data are represented as means ± SEM. **p < 0.01 vs. indicated group ▵▵ p < 0.01 vs. control group (LPS=0ng/mL).
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on phosphorylation of NF-κB p65, a feature of NF-κB activation. 
The results showed that the phosphorylated level of p65 was sig-
nificantly increased from 60 min after LPS stimulation; however, 
Que pretreatment could attenuate this pattern (Figures 5B,C,E). 
Together, these data indicate that Que can inhibit NF-κB activa-
tion in N9 cells induced by LPS.
DiscUssiOn
In the last decade, structural and functional changes in glial cells 
have been becoming a major focus of interest in the research of 
SZ (Zheng et al., 2008). In our present study, we demonstrated 
that microglial activation was associated with the impairment 
of myelin repair in chronic CPZ-induced demyelination mouse 
model. In addition, we demonstrated that the atypical APD Que 
can inhibit the process of microglial activation and promote mye-
lin repair. We further found that Que can suppress the abnormal 
STIM1-mediated elevation of [Ca2+]i and inhibit the activation of 
NF-κB pathway in LPS-induced microglial cultures. As a result, 
the inhibitory effects of Que on microglial activation may have 
important implications for its therapeutic application in SZ.
Cuprizone or biscyclohexnaone oxalyldihydrazone is a  copper 
chelator that selectively damages oligodendrocytes. As such, it 
is a model that has been widely used to induce demyelination. 
Interestingly, the CPZ-induced demyelination mouse model is 
also accepted as a SZ model, in which many cognitive functions 
or behavioral alterations associated with SZ patients are mapped 
(Makinodan et al., 2009; Xu et al., 2009; Xu et al., 2010; Xu et al., 
2011; Praet et  al., 2014). Que is currently used in the clinical 
treatment of SZ. Previous studies indicated that it prevents 
CPZ-induced white matter pathology and behavioral abnor-
malities in a short-term feeding (Zhang et al., 2008; Xu et al., 
2010; Chandran et al., 2012). To understand the mechanism that 
may underlie the progression of white matter abnormality to a 
chronic state, we used the chronic CPZ treatment mouse model, 
in which the long-term (12 weeks) feeding of CPZ induced a 
series of demyelination/remyelination episodes, leading to the 
formation of chronic lesion in white matter (Matsushima and 
Morell, 2001). We found that long-term CPZ treatment induced 
serious demyelination and persistent microglial activation even 
after CPZ was withdrawn. These findings indicate that microglial 
activation may cause impairment of remyelination, since some 
FigUre 3 | effect of Que on ca2+ release and ca2+ entry in n9 cells induced by lPs or Tg. (a) Ca2+ image of N9 cells with LPS stimulation in Ca2+-free 
medium following by Ca2+ (2 mM) buffer incubation after wash with or without Que (10 μM) pretreatment. The first peak shows [Ca2+]i elevation due to release of 
internal ER Ca2+ induced by LPS; the second peak is due to Ca2+ influx through the PM, namely ER Ca2+ store-operated Ca2+ entry (SOCE). Pretreatment of Que 
reduces the [Ca2+]i elevation induced by LPS (red) (20–25 cells were analyzed in each group). (B) Quantification of Ca2+ release (left peak) and store-operated Ca2+ 
entry (SOCE) (right peak) in N9 cells activated by LPS with or without Que pretreatment. (c) Ca2+ image of N9 cells with Tg stimulation in Ca2+-free medium 
following by Ca2+ (2 mM) buffer incubation after wash with or without Que pretreatment (20–25 cells were analyzed in each group). (D) Quantification of Ca2+ 
release (left peak) and store-operated Ca2+ entry (SOCE) (right peak) in N9 cells activated by Tg with or without Que pretreatment. Values are means ± SEM. 
*p < 0.05 and **p < 0.01 vs. CTL.
FigUre 4 | effect of Que on expression of sOce channel proteins in n9 cells exposed to lPs. Quantification of qRT-PCR showed (a) STIM1 mRNA,  
(B) Orai1 mRNA, and (c) STIM2 mRNA in N9 cells exposed to LPS with or without 24 h of Que (10 μM) pretreatment. Values are normalized to GAPDH, a loading 
control. All data are means ± SEM. *p < 0.05, and **p < 0.01 vs. indicated group.
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FigUre 5 | effect of Que on activation of nF-κB in n9 cells induced by lPs. (a) Representative double IF staining of NF-κB p65 (green) and CD11b (red) in 
N9 cells exposed in LPS with or without Que (10 μM) pretreatment, nuclei were stained with DAPI (blue). Note: the arrow indicated positive staining in the nucleus. 
Scale bars: 50 μm. (D) Quantification of the relative ratio of nucleus NF-κB p65 in the indicated groups. Note: LPS significantly increased the ratio of nucleus NF-κB 
p65, which could be reduced by Que pretreatment. (B,c) Western blot analysis of phosphorylated NF-κB p65 in N9 cells exposed in LPS with or without Que 
pretreatment at indicated time points. β-actin was used as a loading control. Note: the phosphorylated NF-κB p65 level was increased since 60 min after LPS 
treatment, and this pattern was attenuated by Que. (D,e) Quantification of the Western blot showing phosphorylated levels of NF-κB p65 in N9 cells exposed to 
LPS with or without Que pretreatment. Values are mean ± SEM. *p < 0.05 and **p < 0.01 vs. indicated group.
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cytokines such as INF-γ or Interleukin-1 (IL-I) was found to 
inhibit oligodendroglia differentiation (Vela et al., 2002; Mana 
et  al., 2006). The proper modulation of activated microglia, 
however, has been shown to be an integral step in the promo-
tion of CNS remyelination by facilitating the increased produc-
tion of neurotrophins or decreasing chemokine expression 
(Butovsky et  al., 2006; Emmetsberger and Tsirka, 2012; Zhou 
et al., 2015). In our study, we demonstrate that Que treatment 
during the recovery period can attenuate microglial activation 
and enhance myelin repair. Our research findings are also sup-
ported by other researchers that have also shown the beneficial 
effects of Que in regard to remyelination (Zhang et al., 2012). 
The findings presented by these researchers suggest that the 
ability of Que to inhibit microglial activation may represent an 
important mechanism underlying its effectiveness at promoting 
remyelination. Normally, cytokines are virtually undetectable in 
the CNS. As such, when cytokines and chemokines are found in 
the CNS, it is usually indicative of clinical conditions involving 
demyelination (Schmitz et al., 2007; Puntambekar et al., 2015), 
brain trauma (Tasker, 2006), and/or mental disorders such as 
SZ (Potvin et al., 2008). Therefore, our current research further 
suggests that manipulating the microglial activation may be 
a key step in facilitating myelin repair that can be pursued as 
a novel treatment approach for SZ and/or other white matter 
disorders.
In regard to the specific mechanisms by which Que affects 
microglia, we demonstrate that Que can modulate STIM1-
mediated intercellular calcium elevation induced by LPS. As 
an important second message molecule, elevation of cytosolic 
Ca2+ has an essential role in microglial activation, including 
proliferation, migration, ramification, and release of proin-
flammatory cytokines and neurotrophins such as brain-derived 
neurotrophic factor (BDNF) (Mizoguchi et al., 2014). Although 
Ca2+ entry across the plasma membrane (PM) is mediated by 
various channels, SOCE channels have been identified as the 
prevalent Ca2+ entry mechanism in non-excitable cells, such as 
microglia (Laskaris et al., 2015). SOCE is controlled by stromal 
interaction molecule (STIM1 or STIM2) on the membrane of 
ER and Orai1 on PM. STIM1 acts as ER Ca2+ sensor (Liou et al., 
2005; Roos et al., 2005) and as such can activate Ca2+ release-
activated Ca2+ (CARC) channels via interaction with Orai 
(Moccia et al., 2015). It has been shown that STIM1 is required 
for SOCE in immune cells and loss of function or null mutations 
in human STIM1 gene stops Ca2+ influx in T cells resulting in 
immunodeficiencies in affected patients (Feske, 2009; Fuchs 
et  al., 2012). Previous study also showed that Orai1–STIM1 
interaction on PM can mediate Ca2+ influx, thereby regulating 
cytokine release in microglia (Sun et al., 2014; Laskaris et al., 
2015). Pharmacological inhibitors and knockdown experiments 
using siRNA for Orai1 and STIM1 revealed that the inhibition 
of Ca2+ influx through SOCE diminished the secretion of 
cytokines, TNF-α and IL-6 (Heo et  al., 2015). In the present 
study, we demonstrate that Que did not modulate basal level of 
cytosolic Ca2+; however, it can ameliorate LPS- and Tg-induced 
elevation of Ca2+ influx via neutralizing the upregulation of 
STIM1. Based on our understanding in this area, it is the first 
time that the regulatory effect of Que on the SOCE channel 
that is involved in microglial activation is shown. However, the 
exact molecular mechanism how Que modulates SOCE still 
requires further investigation. Our research findings suggest 
that manipulating SOCE may represent a novel approach to 
attenuate the chronic disease progression associated with SZ. 
In addition, our research also suggests that STIM1 is a novel 
regulatory target for neutralizing microglial activation that may 
be advantageous in the prevention of progression of various 
neurodegenerative diseases or mental illness.
Following elevation of cytosolic Ca2+, several downstream 
signaling pathways, such as NF-κB activation, are primarily 
responsible for microglial activation (Chauhan et  al., 2014). 
NF-κB is a transcription factor that can be involved in multiple 
cell behaviors such as cell differentiation, survival, apoptosis, 
as well as immune and inflammatory response (Li and Verma, 
2002; Vallabhapurapu and Karin, 2009). It has been reported 
that in AD or ischemia models, Que can inhibit activation of 
NF-κB in neurons (Bi et al., 2009; Zhao et al., 2014). Moreover, 
in an AD mouse model, Que was shown to attenuate glial 
activation and reduce the release of proinflammatory cytokines 
via inhibition NF-κB pathway (Zhu et al., 2015). In the present 
study, we also demonstrate that Que inhibited the transloca-
tion of NF-κB p65 and decreased the phosphorylated levels of 
NF-κB p65 subunits induced by LPS, indicating that the inhibi-
tion effect of Que on microglial activation may due to its effect 
to suppress NF-κB activation. Overall, it is likely that Que can 
maintain the intercellular calcium homeostasis by modulating 
STIM1 expression and subsequently inhibit NF-κB-dependent 
microglial activation.
In summary, within CPZ-induced chronic demyelination 
mouse model in conjunction with an in vitro system involving 
LPS-induced microglial activation cultures, we demonstrate 
that the atypical APD Que can inhibit microglial activation by 
neutralizing abnormal STIM1-mediated intercellular calcium 
homeostasis. In addition, our results also suggest that the abil-
ity of Que to inhibit microglial activation may also promote 
myelin repair. Our research findings identify a novel approach 
of manipulating specific calcium channels to regulate microglial 
activation that contributes to the underlying pathogenesis of SZ.
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